Progress in immunotherapy of myelin oligodendrocyte glycoprotein-IgG associated disorders / 中华神经科杂志

ABSTRACT

Myelin oligodendrocyte glycoprotein-IgG associated disorders (MOGAD) are newly recognized immune-mediated inflammatory demyelinating diseases of the central nervous system. The diseases can be manifested as a single-phase or recurrent course, recurrent episodes of which can leave serious neurological dysfunction, and control of acute attacks and prevention of recurrence is the focus of treatment, including steroids, immunosuppressants and biological agents. This article will review the progress of immunotherapy for MOGAD.